Stay updated on Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.

Latest updates to the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page
- Check4 days agoChange DetectedThe acute myeloid leukemia study is now listed as active but no longer recruiting participants. Its latest record history also notes changes to study design and contact/location information.SummaryDifference1%

- Check11 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe history page shows the contact link label updated from 'Find Contact Information' to 'Find contact information' and adds the revision tag 'Revision: v3.7.0', replacing the previous 'Revision: v3.6.6', reflecting a small UI text normalization and version update in the study record history.SummaryDifference0.2%

- Check53 days agoChange DetectedA new revision entry v3.6.6 is added to the record history and the previous v3.6.5 entry is removed, updating the list of revisions on the page.SummaryDifference0.1%

- Check67 days agoChange DetectedA new revision entry v3.6.5 was added to the history, replacing v3.6.4, signaling a back-end or interface update to the page.SummaryDifference0.1%

- Check89 days agoChange DetectedA new revision entry, Revision: v3.6.4, was added to the history and the previous Revision: v3.6.3 entry was removed, updating the study record's release notes.SummaryDifference0.1%

Stay in the know with updates to Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo with IDH Inhibitors in AML Clinical Trial page.